reference/9278712

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9278712

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	979
issn	1538-8514 1535-7163
issueIdentifier	4
pageRange	972-979
publicationName	Molecular Cancer Therapeutics
startingPage	972
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_140d1bd7303e994025e57514bbf99f67 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1e366eb7dce87dd138fa63e47c7d4adb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_195c9b8cef877e3b9a1d1dbd8ff990ef
bibliographicCitation	Lubet RA, Szabo E, Christov K, Bode AM, Ericson ME, Steele VE, Juliana MM, Grubbs CJ. Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes. Mol Cancer Ther. 2008 Apr;7(4):972–9. doi: 10.1158/1535-7163.mct-07-2141. PMID: 18375820.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_443f0bac4d93a62dc18cd7c032e5be75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9b1fb0c5bc5ea774754c5307657f95f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_499d375ddabe70e5f2afbe9d1749b2b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dcec57c06b3cae018f6ca5317a76c18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fa12745bcc0fc0eec6f8103ef884545 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3891-0942 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf179bf67bcf7cb0397903b2516ec21a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_786726ebc6391a4e789aa08dae38dca0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_319d742ab290d0819fd826d5ee07d9d3
date	2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1535-7163.mct-07-2141 https://pubmed.ncbi.nlm.nih.gov/18375820
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes
discusses	http://id.nlm.nih.gov/mesh/M0461974 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0003416 http://id.nlm.nih.gov/mesh/M0250478 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M0021234 http://id.nlm.nih.gov/mesh/M0013652 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0168136 http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D008325Q000517
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D014230Q000008 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077610 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D007124 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D066246Q000378 http://id.nlm.nih.gov/mesh/D008770 http://id.nlm.nih.gov/mesh/D008325Q000139 http://id.nlm.nih.gov/mesh/D002273 http://id.nlm.nih.gov/mesh/D013764Q000008 http://id.nlm.nih.gov/mesh/D000077156 http://id.nlm.nih.gov/mesh/D008325Q000378 http://id.nlm.nih.gov/mesh/D004359
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82146 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60796 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9818699 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12699 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129705965 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229605 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129944454 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788589 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128675752

Total number of triples: 85.